Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1Areceptors without diminishing nervous system function or chemotherapy efficacy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1Areceptors without diminishing nervous system function or chemotherapy efficacy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 3, Pages 636-645
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/bph.12439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors
- (2013) Fabricio H. Do Monte et al. BEHAVIOURAL BRAIN RESEARCH
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol as potential anticancer drug
- (2012) Paola Massi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- (2012) Wei Xiong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
- (2012) Gabriella Aviello et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy
- (2012) Liting Deng et al. Molecular Pain
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
- (2012) Cristina A J Stern et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice
- (2011) Sara Jane Ward et al. ANESTHESIA AND ANALGESIA
- Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
- (2011) E L Karschner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
- (2011) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
- (2011) Onintza Sagredo et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors
- (2010) Plinio C. Casarotto et al. BEHAVIOURAL PHARMACOLOGY
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- (2010) Sabatino Maione et al. BRITISH JOURNAL OF PHARMACOLOGY
- Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
- (2010) M. A. Ware et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real
- (2010) Andreas A. Argyriou et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
- (2010) Ralf Baron et al. LANCET NEUROLOGY
- Cannabidiol Enhances the Inhibitory Effects of 9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
- (2010) J. P. Marcu et al. MOLECULAR CANCER THERAPEUTICS
- Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
- (2010) Cory C Toth et al. Molecular Pain
- Roles of the rostroventromedial medulla and the spinal 5-HT1A receptor in descending antinociception induced by motor cortex stimulation in the neuropathic rat
- (2010) Hanna Viisanen et al. NEUROSCIENCE LETTERS
- The evidence for pharmacological treatment of neuropathic pain
- (2010) Nanna Brix Finnerup et al. PAIN
- Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors
- (2010) Fernando H.F. Alves et al. PHARMACOLOGICAL RESEARCH
- Mechanical Allodynia Induced by Paclitaxel, Oxaliplatin and Vincristine: Different Effectiveness of Gabapentin and Different Expression of Voltage-Dependent Calcium Channel α2δ-1 Subunit
- (2009) Punam Gauchan et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
- (2008) M Naguib et al. BRITISH JOURNAL OF PHARMACOLOGY
- Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats
- (2008) Rafael M. Bitencourt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors
- (2008) Hiroko Hagiwara et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
- (2008) E. J. Rahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- C-fiber spontaneous discharge evoked by chronic inflammation is suppressed by a long-term infusion of lidocaine yielding nanogram per milliliter plasma levels
- (2008) Wen Hua Xiao et al. PAIN
- Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved
- (2008) Francesca Comelli et al. PHYTOTHERAPY RESEARCH
- Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory
- (2008) John J. Foley et al. PSYCHOPHARMACOLOGY
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
- (2007) J Guindon et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
- (2007) E J Rahn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nabilone for the Treatment of Pain in Fibromyalgia
- (2007) Ryan Quinlan Skrabek et al. JOURNAL OF PAIN
- Experimental Studies of Potential Analgesics for the Treatment of Chemotherapy-Evoked Painful Peripheral Neuropathies
- (2007) Wenhua Xiao et al. PAIN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started